Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.

导出原文传递

翻译打印收藏纠错

作者： van Leth F ^[1] ; Phanuphak P ^[2] ; Ruxrungtham K ; Baraldi E ; Miller S ; Gazzard B ; Cahn P ; Lalloo UG ; van der Westhuizen IP ; Malan DR ; Johnson MA ; Santos BR ; Mulcahy F ; Wood R ; Levi GC ; Reboredo G ; Squires K ; Cassetti I ; Petit D ; Raffi F ; Katlama C ; Murphy RL ; Horban A ; Dam JP ; Hassink E ; van Leeuwen R ; Robinson P ; Wit FW ; Lange JM

作者单位： Univ Oxford, Oxford, England ^[1] International Antiviral Therapy Evaluation Center, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands. ^[2]

关键词 Anti-HIV Agents HIV Infections HIV-1 Nevirapine Oxazines Reverse Transcriptase Inhibitors 抗HIV药 HIV感染奈韦拉平恶嗪类逆转录酶抑制剂

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交